PNPLA3 I148M Variant Influences Circulating Retinol in Adults with Nonalcoholic Fatty Liver Disease or Obesity.
about
The Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic BackgroundThe Role of Vitamins in the Pathogenesis of Non-alcoholic Fatty Liver DiseaseMolecular Pathogenesis of NASHMBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals.Retinoid and carotenoid status in serum and liver among patients at high-risk for liver cancer.The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent.Retinol Binding Protein-4 Levels and Non-alcoholic Fatty Liver Disease: A community-based cross-sectional studyGenetic Variations Associated with Vitamin A Status and Vitamin A Bioavailability.Hepatic Retinyl Ester Hydrolases and the Mobilization of Retinyl Ester Stores.Protein and vitamin B6 intake are associated with liver steatosis assessed by transient elastography, especially in obese individuals.Circulating retinol binding protein 4 levels in nonalcoholic fatty liver disease: a systematic review and meta-analysis.Regulation of retinol-binding protein 4 and retinol metabolism in fatty liver disease.PNPLA3 expression and its impact on the liver: current perspectives.Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD).The PNPLA3 I148M variant is associated with transaminase elevations in type 2 diabetes patients treated with basal insulin peglispro.PNPLA3 overexpression results in reduction of proteins predisposing to fibrosis.Unexpected metabolic disorders induced by endocrine disruptors in Xenopus tropicalis provide new lead for understanding amphibian decline.Coding variants in PNPLA3 and TM6SF2 are risk factors for hepatic steatosis and elevated serum alanine aminotransferases caused by a glucagon receptor antagonist.Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular Carcinoma
P2860
Q26744380-CFD28F22-5861-4060-B2A0-E91E108A86B8Q26752762-B568A484-A47E-4043-A60F-5577954075B3Q28071265-B860D180-C48D-49E4-A9E3-4632DEBBCD62Q33866766-148D0A60-0FD1-4B9B-B8EE-E2D66C41FEB8Q35939958-2A5B226A-F163-44CF-97D8-D445B713971DQ36833028-F0BDA277-5A23-4B91-B7C0-A3CF4B3A8B6AQ37717128-4821B045-C477-4294-91B9-8E624254CE26Q37729744-3B967F0B-FEB1-4BE4-8436-EF14CA0D2DF1Q39062983-5DB0A384-371E-47BA-A73A-3FE977C34A88Q40116780-13ABB57C-708A-4498-BE13-2D8043946620Q41696361-C16EA909-C019-4585-AFC1-33F2DF34814CQ42361308-8024AF89-A857-4010-AD5F-7B3FFB73ED1BQ45414078-EC88A1AA-45FC-49EC-B43B-6F00C68FFED2Q47246053-D509805C-AE39-445D-BB01-A71ECC4EA241Q47436758-DE2B12D3-3011-432C-9741-7216D50F3E09Q51392496-2A88B2A3-8D13-4570-BB6C-5D008D56163EQ52568660-EB4E181E-254D-493D-B671-941997350E26Q55032630-67718336-B35A-4754-8FD6-FAC1D6EEC689Q58693431-C715D5D1-08D3-4D73-9793-607E839AF150
P2860
PNPLA3 I148M Variant Influences Circulating Retinol in Adults with Nonalcoholic Fatty Liver Disease or Obesity.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
PNPLA3 I148M Variant Influence ...... atty Liver Disease or Obesity.
@ast
PNPLA3 I148M Variant Influence ...... atty Liver Disease or Obesity.
@en
type
label
PNPLA3 I148M Variant Influence ...... atty Liver Disease or Obesity.
@ast
PNPLA3 I148M Variant Influence ...... atty Liver Disease or Obesity.
@en
prefLabel
PNPLA3 I148M Variant Influence ...... atty Liver Disease or Obesity.
@ast
PNPLA3 I148M Variant Influence ...... atty Liver Disease or Obesity.
@en
P2860
P50
P356
P1433
P1476
PNPLA3 I148M Variant Influence ...... atty Liver Disease or Obesity.
@en
P2093
Andrea Merlo
Paola Dongiovanni
P2860
P304
P356
10.3945/JN.115.210633
P407
P50
P577
2015-07-01T00:00:00Z